Capstone Investment Advisors, LLC Moderna, Inc. Call Options Transaction History

Capstone Investment Advisors, LLC

$29.5 Billion
Q2 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $657,865 - $1.08 Million	6,500 Added 36.31%	24,400 $2.9 Million
Q1 2024 May 01, 2024	SELL	$85.37 - $115.44 $2.72 Million - $3.68 Million	-31,900 Reduced 64.06%	17,900 $1.91 Million
Q4 2023 Feb 12, 2024	BUY	$69.51 - $104.43 $2.54 Million - $3.81 Million	36,500 Added 274.44%	49,800 $4.95 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $327,794 - $430,474	3,400 Added 34.34%	13,300 $1.37 Million
Q2 2023 Aug 10, 2023	BUY	$118.5 - $160.53 $272,550 - $369,219	2,300 Added 30.26%	9,900 $1.2 Million
Q1 2023 May 09, 2023	BUY	$135.66 - $197.02 $122,094 - $177,318	900 Added 13.43%	7,600 $1.17 Million
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $130,218 - $231,044	1,100 Added 19.64%	6,700 $1.2 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $35,421 - $58,254	300 Added 5.66%	5,600 $662,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $4.51 Million - $6.8 Million	-38,500 Reduced 87.9%	5,300 $757,000
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $3.28 Million - $6.09 Million	25,900 Added 144.69%	43,800 $7.55 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $858,116 - $1.4 Million	3,800 Added 26.95%	17,900 $4.55 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $3.13 Million - $6.83 Million	14,100 New	14,100 $5.43 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $1.14 Million - $1.93 Million	-10,400 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $289,256 - $747,384	-4,400 Reduced 29.73%	10,400 $1.09 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $804,232 - $1.4 Million	14,800 New	14,800 $1.05 Million

Others Institutions Holding MRNA

# of Institutions

1,112

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $23.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account